Over the last two decades, healthcare costs have become a major topic of conservation and a major worry for governments, businesses, healthcare providers and private citizens. Medicare and Medicaid capture nearly one-quarter of the U.S. federal budget, while according to Bloomberg, healthcare takes up more than 15% of consumer spending. Healthcare costs have likewise loomed large for many corporate pension plans and many companies have cut or stopped subsidizing health insurance costs for workers.

So, what are the biggest items on the national healthcare bill? While there are a lot of complicating factors in the math (as well as double-counting), it's fairly clear that heart disease, obesity, diabetes and cancer make some of the largest demands on the U.S. healthcare budget.

A Note on Math
Unfortunately, calculating the cost of various diseases is not a straightforward exercise. Not only are there issues of advocacy to consider (patient and research groups have an incentive to make their particular cause look more important), but the line between direct and indirect cost can be blurry at best. Likewise, double-counting is a major problem – obesity, hypertension, diabetes, and heart disease often overlap and co-present and it can be very difficult (if not impossible) to properly tease out which dollar should be allocated to which disease.

Heart Disease
It is not surprising that heart disease often features prominently on lists of expensive diseases. Estimates of the cost of heart disease range from around $100 billion to more than $440 billion, according to the Centers of Disease Control and Prevention. Unfortunately, this is an area rife with double-counting. "Core" coronary disease (atherosclerosis, high cholesterol, heart attack, bypass and so on) is believed to count for nearly $110 billion in annual costs, while hypertension (over $90 billion) and stroke ($54 billion) are often included as well. Drilling a little deeper, Forbes reports that congestive heart failure alone is thought to demand about $33 billion to $34 billion a year in annual U.S. healthcare expenditures.

Diabetes
Diabetes was once a relatively uncommon autoimmune disease (Type 1 diabetes), but has since become a major healthcare problem due to the spread of obesity-related Type 2 diabetes. Diabetes itself requires money to manage - in the form of oral medications, injected medications, insulin, glucose testing products and so on.

There are also costs tied to additional healthcare services (emergency visits for hypoglycemia, for instance), but the biggest issue with diabetes is that it significantly increases the likelihood of cardiovascular, kidney, vision and other health problems. Estimates of the direct cost of diabetes start at around $46 billion, while the American Diabetes Association projects total costs of $174 billion, with nearly $60 billion of that coming from the admittedly hard-to-prove "reduced national productivity."

Obesity
Obesity highlights the somewhat fuzzy math that goes into projecting total systemic costs for specific diseases or conditions. Estimates for the cost of obesity often range from nearly $150 billion to almost $200 billion, with one source estimating $45 billion in in-patient costs and $69 billion in drug costs. Unfortunately, those numbers are a bit dubious. There are relatively few prescriptions written for weight loss drugs (though companies like Vivus and Arena hope to change this), and likewise there are relatively few procedures or hospitalizations specific for obesity. Instead, obesity is a known contributor to heart disease, cancer, joint damage and many other expensive-to-treat conditions. Likewise, the cost of over-the-counter spending on "diet" or "lite" products is hard to gauge, as well as spending on weight-loss supplements or products, or services like those provided by Weight Watchers and Jenny Craig.

Cancer
As cancer doesn't really lead to other diseases or conditions, attributing the economic impact of cancer should be easier. While the American Cancer Society does estimate that the indirect costs of cancer exceed $120 billion, sources like ACS and the National Cancer Institute broadly agree on the direct costs of cancer - from around $100 billion to $125 billion a year. Breast cancer is the biggest consumer of economic resources at over $16 billion in direct costs, while colorectal, lung, lymphoma and prostate cancer all cost over $10 billion a year to treat.

Other Diseases and Conditions of Note
With the previously mentioned warnings about the dangers of double-counting, there are several other conditions and diseases that constitute sizable economic burdens to the U.S. healthcare system. Estimates of the cost of respiratory diseases like COPD and asthma run as high as $54 billion according to Web MD, with estimates for the direct cost of asthma (medications, hospitalization, etc.) running between $10 billion and $15 billion. Estimates for the cost of mental illness run from $48 billion to more than $100 billion, with Alzheimer's disease advocates frequently pointing to the high cost of nursing home and supportive care.

Arthritis is believed to cost the healthcare system at least $8 billion a year, while some sources estimate nearly $60 billion in total costs for "joint problems" that include chronic back issues (which alone are estimated to be over $35 billion a year). Last and certainly not least, though it doesn't often garner much discussion, the cost of treating sepsis (severe infection that can be caused by several bacteria) is estimated at over $15 billion a year.

The Bottom Line
Examining the most costly diseases in America brings home several key points. First, the U.S. spends a truly enormous amount of money on diseases that are in many cases avoidable with a commitment to healthier living. Second, there are numerous ways to calculate the cost of a disease, and that makes it a little easier to produce eye-popping numbers when the circumstances call for it.

Related Articles
  1. Stock Analysis

    2 Catalysts Driving Intrexon to All-Time Highs

    Examine some of the main reasons for Intrexon stock tripling in price between 2014 and 2015, and consider the company's future prospects.
  2. Mutual Funds & ETFs

    ETF Analysis: ProShares UltraPro Nasdaq Biotech

    Obtain information about an ETF offerings that provides leveraged exposure to the biotechnology industry, the ProShares UltraPro Nasdaq Biotech Fund.
  3. Mutual Funds & ETFs

    ETF Analysis: SPDR S&P Insurance

    Learn about the SPDR S&P Insurance exchange-traded fund, which follows the S&P Insurance Select Industry Index by investing in equities of U.S. insurers.
  4. Stock Analysis

    5 Reasons Thoratec Corp. Keeps Impressing Investors

    Learn about Thoratec Corporation and its position in its industry. Understand five key factors why the company has impressed investors.
  5. Markets

    The 5 Biggest Canadian Insurance Companies

    Learn more about the insurance industry as a whole, how it functions in Canada, and the five largest Canada-based insurance companies.
  6. Stock Analysis

    The 2 Healthcare Stocks You'll Wish You Bought in 2015

    Learn about the health care industry and the companies involved. Understand why the two best performing health care stocks in 2015 did so well.
  7. Stock Analysis

    The 5 Worst Health Care Stocks of 2015

    Learn about the health care industry and how it has performed in 2015. Understand why the worst-performing health care stocks of 2015 have underperformed.
  8. Entrepreneurship

    How Does ClassPass Work and Make Money?

    Find out how ClassPass makes money, how the company aims to help both businesses and consumers, and why it has been so successful.
  9. Stock Analysis

    Healthcare M&A and Prescription Drug Prices

    Learn how mergers among health care insurance companies and drug companies could lead to increased premiums for consumers and lower drug costs.
  10. Stock Analysis

    3 Stocks You Wish You Had Bought in January

    Learn about three stocks investors wish they had bought in January of 2015 due to their performing better than the overall market.
RELATED TERMS
  1. Net Collections

    A term used in medical accounting to describe the amount of money ...
  2. Corridor Deductible

    Expenses that are paid by the insured in excess of an insurance ...
  3. Insurance Consortium

    A group of businesses or organizations that join together to ...
  4. Mobile Health

    Mobile health is the practice of medicine using new mobile technologies.
  5. Blanket Medical Expense

    An insurance policy which provides coverage for all medical expenses ...
  6. Classified Insurance

    Insurance coverage provided to a policyholder that is considered ...
RELATED FAQS
  1. What role does the agency problem play in the modern Health Care industry?

    Agency problems vary from health care system to health care system, and not all economists agree on the degree and desirability ... Read Full Answer >>
  2. What happens if my insurance claim falls below the deductible level?

    Though the ins and outs of health insurance are often confusing, the concept of the insurance deductible is relatively straightforward. ... Read Full Answer >>
  3. How is the deductible I paid for my insurance claim treated for tax purposes?

    The deductible you pay on your health insurance policy may be tax-deductible if you meet certain conditions. However, whether ... Read Full Answer >>
  4. What are the main factors that impact share prices in the insurance sector?

    The main factors that impact share prices in the insurance sector are interest rates, earnings and actuarial risk. In the ... Read Full Answer >>
  5. Why do insurance policies have deductibles?

    Insurance policies have deductibles for behavioral and financial reasons. Moral Hazards Deductibles mitigate the behavioral ... Read Full Answer >>
  6. Which emerging markets are seeing the strongest growth in the insurance sector?

    The emerging market economies seeing the strongest growth for the insurance sector are primarily the main emerging market ... Read Full Answer >>

You May Also Like

Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!